Topics
September 2017 | In The Back
Share:
By Brian C. Joondeph, MD, MPS
retinatoday.com/2017/08/
September 2017
Paola Dorta S., MD, MHA, and Andrés Kychenthal B., MD
Timothy G. Murray, MD, FACS
Gone With The Flare: Demystifying Uveitis
Sponsored by Santen
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored by Allergan
PASCAL Endpoint Management: Subthreshold Laser Therapy for Macular Diseases
Sponsored by Topcon
Treatment Paradigms in AMD Management: Assessing Consistent Long-Term Dosing (Part 2 of 2)
Supported by an unrestricted educational grant from Regeneron Pharmaceuticals, Inc.
Clinical Case Compendium: Surgical Case Discussions From Thought Leaders
Editorially independent supported by advertising from Alcon and Topcon.
Recent Supplements
Understanding Fast Progression in Geographic Atrophy
View Insert
Gaining Patients’ Buy-in With Geographic Atrophy Treatment: The Journey From Diagnosis to Long-term Adherence
Editorially Independent Content, Supported With Advertising From Astellas
Business Matters: When and How To Hire
Editorially independent content supported with advertising by EyePoint
View Supplement
One to Watch: Samir N. Patel, MD
Editorially independent supported by Abbvie and Regenxbio
Rising Stars in Retina: Prashant D. Tailor, MD
Signaling for Sustained Change: Spotlight on the Potential of TKIs to Deliver Durable Control of Exudative Retinal Disease
This activity is supported by an independent educational grant from EyePoint Pharmaceuticals.
View More
Eyetube Retina Series
EYETUBE RETINA MEETING COVERAGE